Sanofi-Aventis SA Company Information
Employees at Sanofi-Aventis SA
Showing 14 of 67383| JOB TITLE | WORK EMAIL | WORK PHONE | LOCATION | |
|---|---|---|---|---|
| Employee | @sanofi.com | - |
Georgia | VIEW PROFILE |
| Medical Representative | @sanofi.com | - |
VIEW PROFILE | |
| Clinical Research Head | @sanofi.com | - |
VIEW PROFILE | |
| Regional Clinical Trial Manager | @sanofi.com | - |
VIEW PROFILE | |
| Chemietechniker | @sanofi.com | - |
Neuhausen, Bayern | VIEW PROFILE |
| Medical Hospital Operations Director | @sanofi.com | - |
VIEW PROFILE | |
| Employee | @sanofi.com | - |
VIEW PROFILE | |
| Employee | @sanofi.com | - |
Columbia, South Carolina | VIEW PROFILE |
| Marketing Manager Cosmetics and Pharma | @sanofi.com | - |
London, Londo | VIEW PROFILE |
| Production Incharge | @sanofi.com | - |
VIEW PROFILE | |
| Therapeutic Area Head Strategic Development Us Global Pharmacovigilance | @sanofi.com | - |
Wayland, Massachusetts | VIEW PROFILE |
| Conseiller En Développement Des Ventes | @pfizer.com | - |
VIEW PROFILE | |
| Manager | @sanofi.com | - |
VIEW PROFILE | |
| Financial Analysis | @sanofi.com | - |
VIEW PROFILE |
Employee
Georgia 
Medical Representative
Clinical Research Head
Regional Clinical Trial Manager
Chemietechniker
Neuhausen, Bayern Medical Hospital Operations Director
Employee
Employee
Columbia, South Carolina Marketing Manager Cosmetics and Pharma
London, Londo Production Incharge
Therapeutic Area Head Strategic Development Us Global Pharmacovigilance
Wayland, Massachusetts Conseiller En Développement Des Ventes
Manager
Financial Analysis
Enter an employee name to search and verify work emails, phone numbers and social links etc.
Sanofi-Aventis SA's Email Format
We found 3 email formats used by Sanofi-Aventis SA employees. The most common Sanofi-Aventis SA email format is first.last ex.(jane.doe@sanofi.com) being used 93% of the time.
| FORMAT | % | ||
|---|---|---|---|
| First.last | jane.doe@sanofi.com | 93% | |
| First_initial Last | jdoe@sanofi.com | 3% | |
| Others | @sanofi.com | 2% |
